We are live on ! Find out more
CAPR icon

Capricor Therapeutics
CAPR

12 hedge funds and large institutions have $283K invested in Capricor Therapeutics in 2019 Q2 according to their latest regulatory filings, with 1 funds opening new positions, 3 increasing their positions, 5 reducing their positions, and 6 closing their positions.

New
Increased
Maintained
Reduced
Closed

1.89% more ownership

Funds ownership: 0.57% → 2.46% (+1.9%)

29% less funds holding

Funds holding: 17 → 12 (-5)

40% less repeat investments, than reductions

Existing positions increased: 3 | Existing positions reduced: 5

65% less capital invested

Capital invested by funds: $820K → $283K (-$537K)

83% less first-time investments, than exits

New positions opened: 1 | Existing positions closed: 6

Holders
12
Holders Change
-5
Holders Change %
-29.41%
% of All Funds
0.26%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
1
Increased
3
Reduced
5
Closed
6
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
Geode Capital Management
Geode Capital Management
Massachusetts
+$4.92K
2
Royal Bank of Canada
Royal Bank of Canada
Ontario, Canada
+$2.65K
3
Bank of America
Bank of America
North Carolina
+$1.45K
4
Morgan Stanley
Morgan Stanley
New York
+$293

Top Sellers

Rank Fund Capital Flow
1
Brown Advisory
Brown Advisory
Maryland
-$270K
2
Citadel Advisors
Citadel Advisors
Florida
-$36K
3
AA
Apriem Advisors
California
-$23K
4
Northern Trust
Northern Trust
Illinois
-$21K
5
UBS Group
UBS Group
Switzerland
-$16K
Name Holding Trade Value Shares
Change 		Change in
Stake
Vanguard Group
1
Vanguard Group
Pennsylvania
$100K -$2.67K -638 -2%
Brown Advisory
2
Brown Advisory
Maryland
$69K -$270K -64,565 -76%
Geode Capital Management
3
Geode Capital Management
Massachusetts
$43K +$4.92K +1,176 +10%
CBA
4
Coastal Bridge Advisors
Connecticut
$36K -$4.2K -1,002 -8%
US Bancorp
5
US Bancorp
Minnesota
$25K -$4 -1 -0%
BlackRock
6
BlackRock
New York
$2K -$15.5K -3,703 -86%
HIIFS
7
Harel Insurance Investments & Financial Services
Israel
$2K – – –
Bank of America
8
Bank of America
North Carolina
$2K +$1.45K +346 +136%
Royal Bank of Canada
9
Royal Bank of Canada
Ontario, Canada
$2K +$2.65K +633 +21,100%
CFN
10
Cordasco Financial Network
Florida
$1K – – –
LTFS
11
Ladenburg Thalmann Financial Services
Florida
$1K – – –
Citadel Advisors
12
Citadel Advisors
Florida
– -$36K -7,701 Closed
AA
13
Apriem Advisors
California
– -$23K -5,000 Closed
Northern Trust
14
Northern Trust
Illinois
– -$21K -4,592 Closed
UBS Group
15
UBS Group
Switzerland
– -$16K -3,370 Closed
Bank of New York Mellon
16
Bank of New York Mellon
New York
– -$11K -2,430 Closed
FANJ
17
Financial Architects (New Jersey)
New Jersey
– -$1K -200 Closed
Morgan Stanley
18
Morgan Stanley
New York
– +$293 +70 New

CAPR Hedge Fund Activity: Q2 2019 in Review

12 of the 4,604 institutional investors tracked by Wall St. Rank reported a position in Capricor Therapeutics (CAPR) for Q2 2019, worth a combined $283K — down 65% from $820K a quarter earlier.

Sellers outnumbered buyers: 6 funds closed out of CAPR and 1 opened new positions — a net loss of 5 holders — while 5 trimmed existing stakes and 3 added.

The largest buyer was Geode Capital Management, adding an estimated $4.92K. The largest seller was Brown Advisory, cutting an estimated $270K.

  • 12 institutional investors held Capricor Therapeutics (CAPR) as of Q2 2019, down from 17 in Q1 2019.
  • Funds reported $283K of Capricor Therapeutics stock for Q2 2019, down 65% quarter-over-quarter.
  • 1 fund opened new Capricor Therapeutics positions in Q2 2019 and 6 closed out, a net change of -5 holders.
  • The largest Capricor Therapeutics buyer in Q2 2019 was Geode Capital Management, an estimated $4.92K added.
  • The largest Capricor Therapeutics seller in Q2 2019 was Brown Advisory, an estimated $270K sold.

Based on aggregated 13F filings for Q2 2019.